News

You are here

Nov 29, 2018

Iproteos, IBEC and the Vall d’Hebron Research Institute (VHIR) are set to develop an innovative treatment to slow down, stop and even reverse the growth of solid tumors, which represent more than 90% of cancer cases.

It’s a family of peptidomimetic drugs based on a totally new anti-tumor action mechanism, the result of several years of research by Pere Roca-Cusachs’ group at IBEC.

The Translational Research Group on Cancer in Children and Teenagers at VHIR will evaluate candidate drugs, developed with Iproteos’ IPROTech technology, in pediatric tumours in vitro and in vivo.

The project, which received €935,000 from the Ministry of Science, Innovation and Universities through of the call Retos Colaboración, will focus in its first phase on two of the most common solid tumors in children and adolescents, rhabdomyosarcoma and neuroblastoma, as well as in lung and colon cancer, which have the highest mortality rate in adults.

May 23, 2018

Iproteos and the IRB research group of Design, Synthesis and Structure of Peptides and Proteins, led by Prof. Ernest Giralt, have published an article entitled “Targeted covalent inhibition of prolyl oligopeptidase (POP): discovery of sulfonylfluoride peptidomimetics" The study has been performed in collaboration with the University of Glasgow (Scotland, UK) and the Utrecht Institute for Pharmaceutical Sciences (the Netherlands).

May 22, 2018

On Tuesday 12th of June 2018, Iproteos will celebrate an Ordinary and Extraordinary General Meeting. More information is given in the link below.

El Martes 12 de Junio de 2018, Iproteos celebrará una Junta General Ordinaria y Extraordinaria. Se puede encontrar toda la información necesaria en el siguiente enlace:

JUNTA GENERAL ORDINARIA 12 DE JUNIO DE 2018.pdf

 

May 22, 2018

On Wednesday, 30th of May 2018, Iproteos will celebrate the Trade Union assembly. More information is given in the link below.

El miércoles, 30 de Mayo de 2018, Iproteos celebrará una Asamblea del Sindicato de Voto. Se puede encontrar toda la información necesaria en el siguiente enlace: 

ASAMBLEA DEL SINDICATO 30 DE MAYO DE 2018.pdf

Mar 19, 2018

Last 20th of February, Teresa Tarragó, CEO of Iproteos, together with Ignasi Belda, General Director of Barcelona Science Park participated at the radio program named “Preferències” at Radio 4. In a monthly basis, the program covers innovative and scientific issues with Ignasi Belda along with a special guest part of the Barcelona Science Park community.

Feb 05, 2018

Last 28th of January, an article by Joaquim Elcacho about the innovation performed at Iproteos was published in La Vanguardia Newspaper. La Vanguardia is one of the most relevant national newspapers.